药物发现
疾病
药品
医学
药理学
生物信息学
内科学
生物
作者
Tong Wu,Ruimei Lin,Pengdi Cui,Jie Yong,Heshui Yu,Zheng Li
标识
DOI:10.1016/j.jpha.2024.101022
摘要
-butylphenol and elemicin showed significant binding and inhibitory effects on AChE and MAO-A. Additionally, 13 compounds, including α-asarone, penetrated the blood-brain barrier (BBB), indicating potential brain target binding, and eight compounds enhanced microglial β-amyloid phagocytosis, aiding in clearing AD pathological substances. Our results demonstrate the effectiveness of deep learning models in developing AD therapies and provide a strong platform for AD drug discovery.
科研通智能强力驱动
Strongly Powered by AbleSci AI